• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE GUNTHER TULIP NAVALIGN JUGULAR VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE GUNTHER TULIP NAVALIGN JUGULAR VENA CAVA FILTER SET; DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Catalog Number IGTCFS-65-1-JUG-TULIP
Device Problems Structural Problem (2506); Appropriate Term/Code Not Available (3191)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Pain (1994); Perforation of Vessels (2135); Anxiety (2328); Depression (2361); Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.Catalog # is unknown but referred to as tulip.Occupation: non-healthcare professional.Investigation: it has not been possible to further investigate or evaluate this alleged event based on the limited information and/or no device failure provided to date.Catalog number and lot number are unknown, however, the alleged tulip is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.
 
Event Description
It is alleged that the patient received a gunther tulip inferior vena cava (ivc) filter on (b)(6) 2019, and the patient was injured without further explanation.Hospital and medical records have been requested, but not yet provided.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Additional information: a2, a4, b1, b5, b6, b7, d1, d4, g4, h4, h6 (patient and device codes) g4 (pma/510k): k172557 investigation: the following allegations have been investigated: vena cava (vc) perforation, bleeding, hematoma, pain, fatigue, nausea, depression, anxiety, post traumatic stress disorder (ptsd), insomnia, fear, disability, physical limitations.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Unknown if the reported bleeding, hematoma, pain, fatigue, nausea, depression, anxiety, post traumatic stress disorder (ptsd), insomnia, fear, disability, and physical limitations directly related to the filter and unable to identify a corresponding failure mode at this point in time.20 devices in lot.To date, no other complaints have been reported against the lot.The associated work order was reviewed.No related/relevant notes were documented.The device is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
Patient allegedly received an implant on (b)(6) 2019 via the right common femoral vein post pulmonary embolism (pe).Patient is alleging vena cava perforation and bleeding.Patient notes and further alleges experiencing "pain in back, fatigue, nausea, cannot sit/stand/lay down without excruciating pain", depression, anxiety and ptsd, unable to sleep, fear, inability to work, disability.Per a computed tomography (ct)abdomen pelvis without contrast: "findings: there is redemonstration of a pericaval hematoma at the level of previously placed ivc filter"."impression: retroperitoneal pericaval hematoma is demonstrated measuring 7.4 x 2.2 x 4 cm on the current examination.Previously, at the same level, this measured 8 x 2.3 x 4.1 cm allowing for limitations due to lack of intravenous contrast.There is a component of the hematoma which extends along the right pelvic sidewall and towards the inferior pole of the right kidney which appears slightly progressed from prior examination".Per a ct abdomen pelvis without contrast: "1.Previous demonstrated hematoma appears essentially stable, and in some areas such as a retrocaval region, perhaps slightly less prominent when compared to the prior examination.Overall, the hematoma appears better organized with more defined margins when compared to the prior examination.No acute osseous findings are seen.2.Ivc filter is again seen and appear stable from the prior examination.An anterior leftward footplate pierces through the ivc wall which is unchanged from the prior examinations".Per a ct abdomen pelvis without contrast: "redemonstration of a infrarenal ivc filter.Previously described retrocaval hematoma has decreased in size in the interval measuring approximately 7.3 by 1.7 x 1.4 cm in greatest dimensions on the current exam compared to 8.5 by 2.4 x 1.7 cm on prior exam.Is also less dense compared to prior exam".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GUNTHER TULIP NAVALIGN JUGULAR VENA CAVA FILTER SET
Type of Device
DTK FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
MDR Report Key11584550
MDR Text Key242805617
Report Number3002808486-2021-01034
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Type of Report Initial,Followup
Report Date 06/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2019
Device Catalogue NumberIGTCFS-65-1-JUG-TULIP
Device Lot NumberE3489154
Was Device Available for Evaluation? No
Date Manufacturer Received05/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Weight147
-
-